To secure funding for new life sciences-related projects, 3,139,700 shares of Cyntec Co., Ltd., a 100% subsidiary of OEP, are to be issued through a third-party allotment. The fundraising amount is approximately 310,830,000 yen, the paid-in price is 99 yen per share, and the funds will be used for investments in new life sciences projects and investments. The payment period runs from 2026\/10\/30 to 2026\/12\/30.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4571","jir_company_name":"NANO Holdings Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-17","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/4571-20260917-01.pdf","jir_short_summary":"To secure funding for new life sciences-related projects, 3,139,700 shares of Cyntec Co., Ltd., a 100% subsidiary of OEP, are to be issued through a third-party allotment. The fundraising amount is approximately 310,830,000 yen, the paid-in price is 99 yen per share, and the funds will be used for investments in new life sciences projects and investments. The payment period runs from 2026\/10\/30 to 2026\/12\/30.","jir_summary":"### Overview\nNANO Holdings has resolved at the board of directors meeting to issue new shares to Cyntec Co., Ltd., a 100% subsidiary of OEP, through a third-party allotment in order to advance strategic capital and business partnerships. The payment period is from 2026\/10\/30 to 2026\/12\/30, the number of issued shares is 3,139,700, the issue price is 99 yen per share, and the total funds raised amount to approximately 310.83 million yen. The funds will be allocated to investments in new life sciences-related projects and investment opportunities.\n\n### Outlook and Risks\nThis allotment aims to strengthen the capital relationship with the OEP Group and to dynamically promote the creation of new life sciences businesses and investments. At present, the specific impact on the results for the fiscal year ending March 2027 is expected to be minimal, and each individual project\u2019s viability and profitability will be evaluated on a case-by-case basis.","jir_financial_highlights":"Number of newly issued shares: 3,139,700 shares (Unclear)\nPaid-in amount: 99 yen (Description includes discount, etc.)\nAmount of funds raised: 310,830,300 yen (Unclear)\nDilution rate: 3.82% (voting rights basis 3.83%) (Unclear)\nPayment period: From October 30, 2026 to December 30, 2026 (Unclear)","jir_category":"","jir_hashtags":"#NANOHoldings, #CapitalPolicy\/AllianceRelated","jir_key_figures":"Number of newly issued shares: 3,139,700 shares (voting rights: 31,397)\nPaid-in amount: 99 yen\/share\nAmount of funds raised: 310,830,300 yen\nDilution rate: 3.82% (voting rights basis 3.83%)\nUse of funds: Investment funds for new life sciences projects and investments","jir_meta_title":"NANO Holdings: Third-Party Allotment Issuance toward Strategic Capital Alliance in Life Sciences | October 2026","jir_meta_description":"NANO Holdings conducts a third-party allotment to Cyntec as part of a strategic capital alliance with the OEP Group. 3,139,700 shares issued, 99 yen paid-in, approximately 310 million yen raised. Funds to be used for new investments in life sciences.","jir_og_title":"NANO Holdings: Issuing New Shares for Life Sciences Capital Alliance | 2026","jir_og_description":"NANO Holdings decides to issue new shares to advance a strategic capital alliance with the OEP Group in the life sciences field. Funds will be allocated to new investment opportunities.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":58963,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-114900","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n